MED: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Revenue	310,692	-
Cost of sales	87,645	-
Selling, marketing, and after sales support	151,883	-
Distribution	13,646	-
Technology	32,731	-
Administrative and corporate support functions	25,730	-
Equity compensation	5,467	-
Other loss (income)	7,153	-
Provision (benefit) for income taxes	1,296	-
Net income (loss)	-553	1,708
Depreciation and amortization	10,777	7,325
Non-cash lease expense	3,459	2,299
Share-based compensation	5,467	4,557
Loss on disposal of property, plant and equipment	-1,001	-395
Realized gain on sale of investment securities	3,303	3,303
Amortization of discount on investment securities	515	0
Deferred income taxes	-648	0
Unrealized (gain) loss on equity investment securities	14	0
Non-cash charges for supply chain optimization	0	-358
Inventories	-19,216	-12,220
Prepaid expenses and other current assets	-2,818	-585
Other assets	169	308
Accounts payable and accrued expenses	-19,610	-19,094
Income taxes	-5,785	-5,998
Net cash flow provided by operating activities	12,141	28
Purchase of investment securities	51,495	31,062
Proceeds from sale and maturities of investment securities	52,780	45,265
Purchase of property and equipment	4,263	2,900
Net cash flow used in investing activities	-2,978	11,303
Options exercised by directors	0	0
Net shares repurchased for employee taxes	370	370
Cash dividends paid to stockholders	195	195
Net cash flow used in financing activities	-565	-565
Foreign currency impact	0	0
Increase in cash and cash equivalents	8,598	10,766
Cash and cash equivalents at beginning of period	90,928	-
Cash and cash equivalents at end of period	99,526	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

MED: the cashflow